Patients with dry age-related macular degeneration who underwent subretinal transplantation of retinal pigment epithelial cells derived from human embryonic stem cells experienced stable or improved vision. “OpRegen eyes appear to tolerate the transplanted cells, may have restored retinal outer layer anatomy, may have slowed geographic atrophy progression, and may have stable or improved vision while […]

Founding CEO John McKearn, Ph.D. is all-in on the pursuit of lower-cost, off-the-shelf, allogeneic CAR T-cell therapies to address a host of oncological indications. Dr. John McKearn is an academic and research scientist turned biotech entrepreneur and venture capitalist. His latest venture, Wugen, is a private, preclinical biopharma taking a novel approach to developing off-the-shelf […]

Psychiatry is an area that Jonathan Javitt never planned to work in. In fact, he still jokes that he flunked a psychiatry class while in medical school. Unfortunately, life has a way of changing your focus. For Javitt, who is now the co-founder and CEO of NeuroRx, that happened 11 years ago when one of […]